Skip to main content

FDA Panel Approves New Liver Drug

An FDA panel has recommended approval of a new drug aimed at treating a rare liver condition, the latest in a burgeoning field of liver-disease treatments.

Lead image for this article

An FDA panel has recommended approval of a new drug aimed at treating a rare liver condition, the latest in a burgeoning field of liver-disease treatments. The liver disease, primary biliary cirrhosis, destroys bile ducts in the liver and can lead to patients requiring liver transplants. (The Wall Street Journal)

Quality journalism doesn't come free

Yes, I'll donate today